255 related articles for article (PubMed ID: 9075230)
21. A drug of the past, a lesson for the future.
Vincenti F
Pediatr Transplant; 2005 Jun; 9(3):267-8. PubMed ID: 15910379
[No Abstract] [Full Text] [Related]
22. Anti-CD3 antibodies.
Chatenoud L; Bach JF
Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
[No Abstract] [Full Text] [Related]
23. T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
Brown S; Lucas B; Waid T; McKeown W; Tsuchida M; Thompson J
Transplant Proc; 1997; 29(1-2):315-6. PubMed ID: 9123017
[No Abstract] [Full Text] [Related]
24. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.
Chatenoud L; Ferran C; Legendre C; Kurrle R; Kreis H; Bach JF
Transplant Proc; 1990 Aug; 22(4):1787-8. PubMed ID: 2117809
[No Abstract] [Full Text] [Related]
25. Accelerated liver allograft rejection during prophylactic immunosuppression with OKT3.
Sasaki AW; Lee RG; Porayko MK; Benner KG; Hennell KR; Wheeler LJ; Pinson CW
Transplantation; 1993 Jan; 55(1):216-9. PubMed ID: 8420054
[No Abstract] [Full Text] [Related]
26. Immunologic monitoring in OKT3-treated kidney graft recipients.
Zlabinger GJ; Maurer D; Ulrich W; Meron G; Pohanka E; Kovarik J
Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
[No Abstract] [Full Text] [Related]
27. The effects of OKT3 anti-rejection therapy on in situ allograft infiltrating lymphocytes.
Kerr PG; Atkins RC
Transplant Proc; 1989 Feb; 21(1 Pt 1):977-8. PubMed ID: 2650302
[No Abstract] [Full Text] [Related]
28. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
[No Abstract] [Full Text] [Related]
29. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
[No Abstract] [Full Text] [Related]
30. Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.
Waid TH; Lucas BA; Thompson JS; Brown S; Moore D; Amlot P; Janossy G
Transplant Proc; 1989 Feb; 21(1 Pt 2):1778-84. PubMed ID: 2652582
[No Abstract] [Full Text] [Related]
31. Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects.
Chatenoud L
Transplant Proc; 1988 Oct; 20(5 Suppl 6):79-83. PubMed ID: 3140452
[No Abstract] [Full Text] [Related]
32. Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Friend PJ; Waldmann H; Hale G; Cobbold S; Rebello P; Thiru S; Jamieson NV; Johnston PS; Calne RY
Transplant Proc; 1991 Aug; 23(4):2253-4. PubMed ID: 1908152
[No Abstract] [Full Text] [Related]
33. Clinical development of Orthoclone OKT3.
Cosimi AB
Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
[No Abstract] [Full Text] [Related]
34. OKT3 delays rejection crises after heart transplantation.
Weimar W; Essed CE; Balk AH; Simoons ML; Hendriks GF; Wenting GJ; Mochtar B; Bos E
Transplant Proc; 1989 Feb; 21(1 Pt 3):2497-8. PubMed ID: 2495641
[No Abstract] [Full Text] [Related]
35. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
Peddi VR; Kamath S; Schroeder TJ; Munda R; First MR
Transplant Proc; 1998 Mar; 30(2):285-7. PubMed ID: 9532041
[No Abstract] [Full Text] [Related]
36. [Muromonab CD3].
Akioka Y; Hattori M; Ito K
Nihon Rinsho; 2005 May; 63 Suppl 5():747-50. PubMed ID: 15954439
[No Abstract] [Full Text] [Related]
37. Safety and patient satisfaction with outpatient-administered OKT3 in combined kidney/pancreaticoduodenal allograft recipients.
Overman JA; Perkins JD
Transplant Proc; 1990 Apr; 22(2):681-2. PubMed ID: 2109389
[No Abstract] [Full Text] [Related]
38. Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss.
David-Neto E; Ribeiro DS; Ianhez LE; Palomino S; Saldanha LB; Arap S; Sabbaga E
Transplant Proc; 1993 Feb; 25(1 Pt 2):897-9. PubMed ID: 8442259
[No Abstract] [Full Text] [Related]
39. Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
Milford EL; Carpenter CB; Kirkman RL; Tilney NL; Mazoujian G; Strom TB; Lazarus JM; Schlossman SF; Guttmann RD; Lowry R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1910. PubMed ID: 3274450
[No Abstract] [Full Text] [Related]
40. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
